New study tracks COVID-19 vaccine response in young cancer patients
NCT ID NCT05228275
First seen Jun 24, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study follows 549 children, teens, and young adults with cancer to see how their immune systems respond to COVID-19 vaccines. Researchers collect blood samples to measure protective antibodies. The goal is to learn how cancer and its treatment affect vaccine effectiveness, and whether timing or extra doses help.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors understand how to best time COVID-19 vaccines for young cancer patients to maximize protection.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures immune responses and does not test whether the vaccine prevents infection. Results may vary by cancer type and treatment stage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 549 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2022
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children and young adults with cancer receiving approved COVID-19 vaccines
- Ages
-
6 months to 37 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \>= 6 months and =\< 37 years of age at time of enrollment * Patient plans to receive their first COVID-19 vaccine dose one of the food and drug administration (FDA) approved/FDA-emergency use authorization (EUA) approved COVID-19 vaccines OR patient already received their first COVID-19 vaccine dose =\< 24 months prior to enrollment using one of the FDA approved/FDA-EUA approved COVID-19 vaccines. * Note: for this observational study, the decision to vaccinate is according to local discretion and should be made prior to consideration of enrollment * Must have a diagnosis of cancer * Patient must be undergoing or have previously received one of the following cancer treatments within 12 months before their first COVID-19 vaccine dose: * Dosing with chemotherapy or immunotherapy agent, including tyrosine kinase inhibitors and small molecule inhibitors targeting cancer * Dosing with monoclonal antibodies targeting B-cell antigens (e.g., Rituximab), or Bruton tyrosine kinase inhibitors or Janus Kinase inhibitors * Stem cell infusion for bone marrow transplant or CAR-T infusion for cellular therapy * A patient enrolling prior to their first COVID-19 vaccine dose is eligible only if it is feasible to collect required baseline study specimens within protocol mandated time period prior to the initial COVID-19 vaccine dose; or a patient who already received a COVID-19 vaccine is eligible only if feasible to collect at least one post-first-dose follow-up specimen (i.e., at minimum, collection of the 24m PFD follow-up specimen must be feasible as per timing requirements * Note: for this observational study, the vaccine timing and regimen will proceed according to local discretion. Patients enrolled prior to their first COVID-19 vaccine dose who do not receive initial vaccine dose within 3 months after enrollment will be taken off study * All patients and/or their parents or legal guardians must sign a written informed consent * All institutional, FDA, and National Cancer Institute (NCI) requirements for human studies must be met Exclusion Criteria: * Documented SARS-CoV-2 monoclonal antibody infusion or convalescent plasma after COVID-19 infection within last 90 days * Note: patients with previous COVID-19 infection are eligible as long as requirements are met. Patients receiving intravenous immunoglobulin therapy (IVIG) therapy (i.e., post bone marrow transplantation \[BMT\] or chimeric antigen receptor \[CAR\]-T) are eligible * Patients undergoing radiation therapy only are ineligible * Reminder: before the planned initial COVID-19 vaccine dose, patient must be undergoing or have received cancer treatments
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Albany Medical Center
Albany, New York, 12208, United States
-
Alfred I duPont Hospital for Children
Wilmington, Delaware, 19803, United States
-
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
Las Vegas, Nevada, 89135, United States
-
Bronson Methodist Hospital
Kalamazoo, Michigan, 49007, United States
-
C S Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
Cardinal Glennon Children's Medical Center
St Louis, Missouri, 63104, United States
-
Children's Hospital and Medical Center of Omaha
Omaha, Nebraska, 68114, United States
-
Children's Hospital at Montefiore
The Bronx, New York, 10467, United States
-
Children's Hospital of Alabama
Birmingham, Alabama, 35233, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Comprehensive Cancer Centers of Nevada - Town Center
Las Vegas, Nevada, 89144, United States
-
Corewell Health Children's
Royal Oak, Michigan, 48073, United States
-
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
Grand Rapids, Michigan, 49503, United States
-
Dayton Children's Hospital
Dayton, Ohio, 45404, United States
-
Dell Children's Medical Center of Central Texas
Austin, Texas, 78723, United States
-
Drexel University School of Medicine
Philadelphia, Pennsylvania, 19102, United States
-
Driscoll Children's Hospital
Corpus Christi, Texas, 78411, United States
-
East Tennessee Childrens Hospital
Knoxville, Tennessee, 37916, United States
-
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida, 33908, United States
-
Hope Cancer Care of Nevada-Pahrump
Pahrump, Nevada, 89048, United States
-
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, 33701, United States
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
-
Kingman Regional Medical Center
Kingman, Arizona, 86401, United States
-
Las Vegas Urology - Cathedral Rock
Las Vegas, Nevada, 89128, United States
-
Las Vegas Urology - Pebble
Henderson, Nevada, 89074, United States
-
Las Vegas Urology - Pecos
Las Vegas, Nevada, 89074, United States
-
Las Vegas Urology - Smoke Ranch
Las Vegas, Nevada, 89128, United States
-
Madigan Army Medical Center
Tacoma, Washington, 98431, United States
-
Maine Children's Cancer Program
Scarborough, Maine, 04074, United States
-
Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, 54449, United States
-
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida, 33021, United States
-
Mercy Hospital Saint Louis
St Louis, Missouri, 63141, United States
-
Methodist Children's Hospital of South Texas
San Antonio, Texas, 78229, United States
-
Montefiore Medical Center - Moses Campus
The Bronx, New York, 10467, United States
-
Montefiore Medical Center-Einstein Campus
The Bronx, New York, 10461, United States
-
Montefiore Medical Center-Weiler Hospital
The Bronx, New York, 10461, United States
-
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida, 32207, United States
-
Nemours Children's Hospital
Orlando, Florida, 32827, United States
-
Nicklaus Children's Hospital
Miami, Florida, 33155, United States
-
OSF Children's Hospital of Illinois
Peoria, Illinois, 61637, United States
-
Oncology Las Vegas - Henderson
Henderson, Nevada, 89074, United States
-
Overlake Medical Center
Bellevue, Washington, 98004, United States
-
Providence Sacred Heart Medical Center and Children's Hospital
Spokane, Washington, 99204, United States
-
Radiation Oncology Associates
Reno, Nevada, 89509, United States
-
Rady Children's Hospital - San Diego
San Diego, California, 92123, United States
-
Renown Regional Medical Center
Reno, Nevada, 89502, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
Sacred Heart Hospital
Pensacola, Florida, 32504, United States
-
Saint Christopher's Hospital for Children
Philadelphia, Pennsylvania, 19134, United States
-
Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa, Florida, 33607, United States
-
Saint Joseph's Regional Medical Center
Paterson, New Jersey, 07503, United States
-
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, 54301, United States
-
Saint Vincent Hospital Cancer Center at Sturgeon Bay
Sturgeon Bay, Wisconsin, 54235-1495, United States
-
Sanford USD Medical Center - Sioux Falls
Sioux Falls, South Dakota, 57117-5134, United States
-
Sinai Hospital of Baltimore
Baltimore, Maryland, 21215, United States
-
Summerlin Hospital Medical Center
Las Vegas, Nevada, 89144, United States
-
Sunrise Hospital and Medical Center
Las Vegas, Nevada, 89109, United States
-
Tampa General Hospital
Tampa, Florida, 33606, United States
-
The Children's Hospital at TriStar Centennial
Nashville, Tennessee, 37203, United States
-
UCSF Benioff Children's Hospital Oakland
Oakland, California, 94609, United States
-
UF Health Cancer Institute - Gainesville
Gainesville, Florida, 32610, United States
-
University Medical Center of Southern Nevada
Las Vegas, Nevada, 89102, United States
-
University of Illinois
Chicago, Illinois, 60612, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
-
University of Virginia Cancer Center
Charlottesville, Virginia, 22908, United States
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine stop GI cancers from returning?
- Can a phone app help childhood cancer survivors keep track of their health?
- Can the way we word cancer research invitations boost participation?
- A chill pill for Chemo's side effects? cooling therapy and a Blood-Flow drug take on nerve pain
- Wearable tech could spot Post-Surgery problems early
- Can an AI chatbot ease the aftermath of cancer?